MHRA’s latest licence update shows ongoing medicines wholesale activity. Learn why WDA(H) readiness, GDP systems and RP oversight matter before market entry.
Faster Medicines Access and GDP Readiness: What Businesses Should Check
MHRA performance updates show faster medicines access in the UK. Learn why GDP readiness, WDA(H) planning and distribution controls matter.
Why Medicine Labelling Controls Matter for GDP Compliance
Recent MHRA updates show why medicine wholesalers need strong labelling, PIL, documentation and GDP quality controls.
Medicine Shortages: Why GDP Escalation Processes Matter
New DHSC medicine supply guidance shows why wholesalers need clear GDP escalation, documentation and communication processes.
Illegal Medicines Network Shows Why GDP Controls Matter
An MHRA illegal medicines case shows why storage, packaging, distribution routes, GDP controls and WDA(H) readiness matter.
Why Stability Failures Matter for GDP Compliance
A recent MHRA recall shows why medicines wholesalers need strong storage, transport, quarantine and GDP quality controls.
Fake Mounjaro Pens Show Why Product Verification Matters
An MHRA fake Mounjaro warning shows why wholesalers need strong product verification, supplier checks and GDP quality oversight.
MHRA Safety Update: Why Product Information Controls Matter
A new MHRA safety update shows why medicine wholesalers need strong product information controls, GDP quality systems and RP oversight.
Why Product Information Controls Matter for GDP Compliance
A latest MHRA defect notice shows why wholesalers need strong product information controls, documentation review and RP oversight.
Why Barcode and GTIN Controls Matter for GDP Compliance
An MHRA barcode defect notice shows why medicines wholesalers need strong stock identification, GDP controls and RP oversight.